SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-015402
Filing Date
2016-07-29
Accepted
2016-07-29 16:46:25
Documents
54
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0616_actiniumpharmac.htm 10-Q 560596
2 CERTIFICATION f10q0616ex31i_actinium.htm EX-31.1 14426
3 CERTIFICATION f10q0616ex32i_actinium.htm EX-32.1 7586
  Complete submission text file 0001213900-16-015402.txt   3139942

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE atnm-20160630.xml EX-101.INS 456008
5 XBRL SCHEMA FILE atnm-20160630.xsd EX-101.SCH 42750
6 XBRL CALCULATION FILE atnm-20160630_cal.xml EX-101.CAL 26796
7 XBRL DEFINITION FILE atnm-20160630_def.xml EX-101.DEF 136475
8 XBRL LABEL FILE atnm-20160630_lab.xml EX-101.LAB 381451
9 XBRL PRESENTATION FILE atnm-20160630_pre.xml EX-101.PRE 240705
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 161794615
SIC: 2834 Pharmaceutical Preparations